Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C
暂无分享,去创建一个
J. McCubrey | P. Suh | L. Cocco | A. Billi | A. Poli | S. Mongiorgi | Stefano Ratti | G. Ramazzotti
[1] Z. Shah,et al. PIP4K and the role of nuclear phosphoinositides in tumour suppression. , 2015, Biochimica et biophysica acta.
[2] Z. Shah,et al. The Basal Transcription Complex Component TAF3 Transduces Changes in Nuclear Phosphoinositides into Transcriptional Output , 2015, Molecular cell.
[3] S. Jhanwar. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview. , 2015, Advances in biological regulation.
[4] W. Blalock,et al. PI‐PLCβ1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro‐B‐lymphoblastic cells exposed to oxidative stress , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] W. Blalock,et al. PLCβ1a and PLCβ1b Selective Regulation and Cyclin D3 Modulation Reduced by Kinamycin F During K562 Cell Differentiation , 2015, Journal of cellular physiology.
[6] R. Irvine,et al. Exploring phosphatidylinositol 5-phosphate 4-kinase function , 2015, Advances in biological regulation.
[7] David R. Jones,et al. A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival , 2014, Oncogene.
[8] Alessandro Poli,et al. PLC and PI3K/Akt/mTOR signalling in disease and cancer. , 2015, Advances in biological regulation.
[9] J. McCubrey,et al. A novel DAG-dependent mechanism links PKCa and Cyclin B1 regulating cell cycle progression , 2014, Oncotarget.
[10] L. Cocco,et al. Protein kinase C involvement in cell cycle modulation. , 2014, Biochemical Society transactions.
[11] O. Yersal,et al. Biological subtypes of breast cancer: Prognostic and therapeutic implications. , 2014, World journal of clinical oncology.
[12] J. McCubrey,et al. PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells , 2014, Oncotarget.
[13] A. Toker,et al. Signaling specificity in the Akt pathway in biology and disease. , 2014, Advances in biological regulation.
[14] Sharon Y. R. Dent,et al. Chromatin modifiers and remodellers: regulators of cellular differentiation , 2013, Nature Reviews Genetics.
[15] J. Chen,et al. Alternative splicing in cancer: implications for biology and therapy , 2014, Oncogene.
[16] Toshiaki Tanaka,et al. DGKζ under stress conditions: “to be nuclear or cytoplasmic, that is the question”. , 2014, Advances in biological regulation.
[17] J. McCubrey,et al. Nuclear PI-PLCβ1: an appraisal on targets and pathology. , 2014, Advances in biological regulation.
[18] Z. Shah,et al. Nuclear phosphoinositides and their impact on nuclear functions , 2013, The FEBS journal.
[19] K. Jirström,et al. Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: A role for PIP4K2B in the regulation of E-cadherin expression. , 2013, Cancer research.
[20] Thomas W. Mühleisen,et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. , 2013, Blood.
[21] John M. Asara,et al. Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors , 2013, Cell.
[22] A. Nakashima,et al. Branched-Chain Amino Acids Enhance Premature Senescence through Mammalian Target of Rapamycin Complex I-Mediated Upregulation of p21 Protein , 2013, PloS one.
[23] R. Irvine,et al. Enzyme activity of the PIP4K2A gene product polymorphism that is implicated in schizophrenia , 2013, Psychopharmacology.
[24] R. Devlin,et al. Acute Physiological Stress Down-Regulates mRNA Expressions of Growth-Related Genes in Coho Salmon , 2013, PloS one.
[25] T. Balla,et al. Phosphoinositides: tiny lipids with giant impact on cell regulation. , 2013, Physiological reviews.
[26] R. Irvine,et al. Evolutionarily conserved structural changes in phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) isoforms are responsible for differences in enzyme activity and localization , 2013, The Biochemical journal.
[27] A. Chokkalingam,et al. Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype. , 2013, Blood.
[28] R. Hasserjian. Acute myeloid leukemia: advances in diagnosis and classification , 2013, International journal of laboratory hematology.
[29] J. McCubrey,et al. K562 cell proliferation is modulated by PLCβ1 through a PKCα-mediated pathway , 2013, Cell cycle.
[30] N. Maraldi,et al. Phosphoinositide-specific Phospholipase C β 1b (PI-PLCβ1b) Interactome: Affinity Purification-Mass Spectrometry Analysis of PI-PLCβ1b with Nuclear Protein* , 2013, Molecular & Cellular Proteomics.
[31] E. Toska,et al. Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase. , 2012, Cell reports.
[32] S. Paolini,et al. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients , 2012, Leukemia.
[33] P. Hawkins,et al. PI3K signalling: the path to discovery and understanding , 2012, Nature Reviews Molecular Cell Biology.
[34] Xu Gao,et al. A microRNA “target pools” remains mysterious , 2012, Journal of cellular biochemistry.
[35] M. Falasca,et al. Phosphoinositides signalling in cancer: focus on PI3K and PLC. , 2012, Advances in biological regulation.
[36] Kim Nasmyth,et al. The cell cycle , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.
[37] Ming-Ming Zhou,et al. The PHD finger: a versatile epigenome reader. , 2011, Trends in biochemical sciences.
[38] Frank B Gertler,et al. The growth cone cytoskeleton in axon outgrowth and guidance. , 2011, Cold Spring Harbor perspectives in biology.
[39] S. Paolini,et al. Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes , 2011, Leukemia.
[40] A. Lamond,et al. Nuclear speckles. , 2011, Cold Spring Harbor perspectives in biology.
[41] R. Reed,et al. A role for TREX components in the release of spliced mRNA from nuclear speckle domains. , 2010, Nature communications.
[42] Willem-Jan Keune,et al. PIP4Kbeta interacts with and modulates nuclear localization of the high-activity PtdIns5P-4-kinase isoform PIP4Kalpha. , 2010, The Biochemical journal.
[43] S. Minucci,et al. Histone deacetylases and epigenetic therapies of hematological malignancies. , 2010, Pharmacological research.
[44] O. Gavet,et al. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. , 2010, Developmental cell.
[45] O. Gavet,et al. Activation of cyclin B1–Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis , 2010, The Journal of cell biology.
[46] A. Martelli,et al. Nuclear inositide signaling in myelodysplastic syndromes , 2010, Journal of cellular biochemistry.
[47] D. Reinberg,et al. Chromatin structure and the inheritance of epigenetic information , 2010, Nature Reviews Genetics.
[48] A. Newton,et al. Protein kinase C: poised to signal. , 2010, American journal of physiology. Endocrinology and metabolism.
[49] P. Zheng,et al. CD24: from A to Z , 2010, Cellular and Molecular Immunology.
[50] Iman van den Bout,et al. PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions , 2009, Journal of Cell Science.
[51] M. Carroll,et al. A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia , 2009, Clinical Cancer Research.
[52] M. Baccarani,et al. Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS , 2009, Proceedings of the National Academy of Sciences.
[53] R. Gambari,et al. Expression of miR-210 during erythroid differentiation and induction of γ-globin gene expression. , 2009 .
[54] C. Bloomfield,et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.
[55] R. Anderson,et al. Two novel phosphatidylinositol-4-phosphate 5-kinase type Iγ splice variants expressed in human cells display distinctive cellular targeting , 2009, The Biochemical journal.
[56] M. Mitchell,et al. Nuclear PLCbeta1 is required for 3T3-L1 adipocyte differentiation and regulates expression of the cyclin D3-cdk4 complex. , 2009, Cellular signalling.
[57] Nicholas J. Wang,et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. , 2009, Cancer research.
[58] S. Armstrong,et al. Chromatin maps, histone modifications and leukemia , 2009, Leukemia.
[59] L. Cocco,et al. Involvement of nuclear PLCβl in lamin B1 phosphorylation and G2/M cell cycle progression , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] Valeria Santini,et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. , 2009, The Lancet. Oncology.
[61] M. Baccarani,et al. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] A. Martelli,et al. Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. , 2009, Advances in enzyme regulation.
[63] A. Martelli,et al. Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. , 2008, Cellular signalling.
[64] Razelle Kurzrock,et al. Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers , 2008, Clinical Cancer Research.
[65] P. Emson,et al. Localization of phosphatidylinositol phosphate kinase IIγ in kidney to a membrane trafficking compartment within specialized cells of the nephron , 2008, American journal of physiology. Renal physiology.
[66] T. Kataoka,et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. , 2008, BMB reports.
[67] M. Okada,et al. Akt phosphorylation and nuclear phosphoinositide association mediate mRNA export and cell proliferation activities by ALY , 2008, Proceedings of the National Academy of Sciences.
[68] K. O’Malley,et al. Activated Nuclear Metabotropic Glutamate Receptor mGlu5 Couples to Nuclear Gq/11 Proteins to Generate Inositol 1,4,5-Trisphosphate-mediated Nuclear Ca2+ Release* , 2008, Journal of Biological Chemistry.
[69] Michael L. Gonzales,et al. A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs , 2008, Nature.
[70] G. Meer,et al. Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.
[71] R. Schneiter,et al. Lipid signalling in disease , 2008, Nature Reviews Molecular Cell Biology.
[72] M. Baccarani,et al. PI-PLCβ-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes , 2008, Leukemia.
[73] M. Cazzola,et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] G. Drin,et al. Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding--how many ways can you activate an enzyme? , 2007, Cellular signalling.
[75] P. Fenaux,et al. Evolving trends in the treatment of low‐risk myelodysplastic syndromes: immunomodulation and beyond—9th European Hematology Association Congress Geneva, Switzerland, 10–13 June 2004 , 2007, Transfusion medicine.
[76] G. Martinelli,et al. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. , 2007, Cancer research.
[77] M. Falasca,et al. Role of class II phosphoinositide 3-kinase in cell signalling. , 2007, Biochemical Society transactions.
[78] Frederick R. Cross,et al. Multiple levels of cyclin specificity in cell-cycle control , 2007, Nature Reviews Molecular Cell Biology.
[79] R. Irvine,et al. The intracellular localisation and mobility of Type Iγ phosphatidylinositol 4P 5-kinase splice variants , 2006, FEBS letters.
[80] Pietro De Camilli,et al. Phosphoinositides in cell regulation and membrane dynamics , 2006, Nature.
[81] C. Finelli,et al. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. , 2006, International journal of molecular medicine.
[82] T. Balla,et al. Phosphatidylinositol 4-kinases: old enzymes with emerging functions. , 2006, Trends in cell biology.
[83] L. Cocco,et al. Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling. , 2006, Biochimica et biophysica acta.
[84] F. Baluška,et al. The Arabidopsis homolog of trithorax, ATX1, binds phosphatidylinositol 5-phosphate, and the two regulate a common set of target genes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[85] P. Piccaluga,et al. Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients , 2006, Leukemia.
[86] S. Minucci,et al. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.
[87] P. Zimmermann,et al. Nuclear speckles and nucleoli targeting by PIP2–PDZ domain interactions , 2005, The EMBO journal.
[88] A. Martelli,et al. Nuclear Phospholipase C β1 (PLCβ1) Affects CD24 Expression in Murine Erythroleukemia Cells* , 2005, Journal of Biological Chemistry.
[89] R. Pazdur,et al. Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes , 2005, Clinical Cancer Research.
[90] Vesna Lukinoviƈ-Škudar,et al. Nuclear phospholipase C-beta1b activation during G2/M and late G1 phase in nocodazole-synchronized HL-60 cells. , 2005 .
[91] H. Lane,et al. The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation , 2005, Cell.
[92] A. Martelli,et al. Nuclear phospholipase C beta1 (PLCbeta1) affects CD24 expression in murine erythroleukemia cells. , 2005, The Journal of biological chemistry.
[93] H. Lane,et al. The mTOR Inhibitor RAD 001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p 21 Translation , 2005 .
[94] A. Shearn,et al. The Direct Interaction Between ASH2, a Drosophila Trithorax Group Protein, and SKTL, a Nuclear Phosphatidylinositol 4-Phosphate 5-Kinase, Implies a Role for Phosphatidylinositol 4,5-Bisphosphate in Maintaining Transcriptionally Active Chromatin , 2004, Genetics.
[95] S. Luoh,et al. Overexpression of the amplified Pip4k2β gene from 17q11–12 in breast cancer cells confers proliferation advantage , 2004, Oncogene.
[96] Voichita D. Marinescu,et al. Expression profiling and identification of novel genes involved in myogenic differentiation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[97] Peter J Parker,et al. PKC at a glance , 2004, Journal of Cell Science.
[98] A. Martelli,et al. Nuclear protein kinase C isoforms: key players in multiple cell functions? , 2003, Histology and histopathology.
[99] David L. Spector,et al. Nuclear speckles: a model for nuclear organelles , 2003, Nature Reviews Molecular Cell Biology.
[100] Junying Yuan,et al. The PHD Finger of the Chromatin-Associated Protein ING2 Functions as a Nuclear Phosphoinositide Receptor , 2003, Cell.
[101] A. Martelli,et al. Up‐regulation of nuclear PLCβ1 in myogenic differentiation , 2003 .
[102] K. Vermeulen,et al. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.
[103] R. Irvine. Nuclear lipid signalling , 2003, Nature Reviews Molecular Cell Biology.
[104] D. Steensma,et al. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. , 2003, Leukemia research.
[105] A. Martelli,et al. Up-regulation of nuclear PLCbeta1 in myogenic differentiation. , 2003, Journal of cellular physiology.
[106] A. Martelli,et al. Nuclear PLCβ1 acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells , 2002 .
[107] C. Downes,et al. Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1. , 2002, The Biochemical journal.
[108] Andrew J. Bannister,et al. Type I PIPkinases Interact with and Are Regulated by the Retinoblastoma Susceptibility Gene Product—pRB , 2002, Current Biology.
[109] P. Janmey,et al. Phosphatidylinositol-dependent actin filament binding by the SWI/SNF-like BAF chromatin remodeling complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[110] J. Lord,et al. Generation of diacylglycerol molecular species through the cell cycle: a role for 1-stearoyl, 2-arachidonyl glycerol in the activation of nuclear protein kinase C-betaII at G2/M. , 2002, Journal of cell science.
[111] A. Martelli,et al. Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells. , 2002, Biochimica et biophysica acta.
[112] H. Kantarjian,et al. Acute myeloid leukemia , 2018, Methods in Molecular Biology.
[113] J. Halstead,et al. Inositol lipids are regulated during cell cycle progression in the nuclei of murine erythroleukaemia cells. , 2001, The Biochemical journal.
[114] G. Schiavo,et al. Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. , 2001, Journal of cell science.
[115] A. Newton,et al. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. , 2001, Chemical reviews.
[116] A. Xu,et al. Protein Kinase C α-mediated Negative Feedback Regulation Is Responsible for the Termination of Insulin-like Growth Factor I-induced Activation of Nuclear Phospholipase C β1 in Swiss 3T3 Cells* , 2001, The Journal of Biological Chemistry.
[117] J. Harbour,et al. The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.
[118] M. Vitale,et al. A Role for Nuclear Phospholipase Cβ1 in Cell Cycle Control* , 2000, The Journal of Biological Chemistry.
[119] F. Gianfrancesco,et al. Identification and chromosomal localisation by fluorescence in situ hybridisation of human gene of phosphoinositide-specific phospholipase C beta(1). , 2000, Biochimica et biophysica acta.
[120] M. Vitale,et al. A role for nuclear phospholipase Cbeta 1 in cell cycle control. , 2000, The Journal of biological chemistry.
[121] A. Martelli,et al. Insulin‐like growth factor‐I‐dependent stimulation of nuclear phospholipase C‐β1 activity in Swiss 3T3 cells requires an intact cytoskeleton and is paralleled by increased phosphorylation of the phospholipase , 1999, Journal of cellular biochemistry.
[122] R. Anderson,et al. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. , 1998, Molecular biology of the cell.
[123] Keji Zhao,et al. Rapid and Phosphoinositol-Dependent Binding of the SWI/SNF-like BAF Complex to Chromatin after T Lymphocyte Receptor Signaling , 1998, Cell.
[124] S. Rhee,et al. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells. , 1998, Cancer research.
[125] F. Hucho,et al. Nuclear import of protein kinase C occurs by a mechanism distinct from the mechanism used by proteins with a classical nuclear localization signal. , 1998, Journal of cell science.
[126] Roger L. Williams,et al. Catalytic Domain of Phosphoinositide-specific Phospholipase C (PLC) , 1998, The Journal of Biological Chemistry.
[127] S. Ryu,et al. Localization of two forms of phospholipase C-beta1, a and b, in C6Bu-1 cells. , 1998, Biochimica et biophysica acta.
[128] L. Cantley,et al. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate , 1997, Nature.
[129] A. Fields,et al. A Role for Nuclear Phosphatidylinositol-specific Phospholipase C in the G2/M Phase Transition* , 1997, The Journal of Biological Chemistry.
[130] N. Divecha,et al. Metabolism and possible compartmentalization of inositol lipids in isolated rat-liver nuclei. , 1997, The Biochemical journal.
[131] H. Perlman,et al. Cell cycle exit upon myogenic differentiation. , 1997, Current opinion in genetics & development.
[132] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[133] J. Loijens,et al. Type I Phosphatidylinositol-4-phosphate 5-Kinases Are Distinct Members of This Novel Lipid Kinase Family* , 1996, The Journal of Biological Chemistry.
[134] Y. Yazaki,et al. Cloning of cDNAs Encoding Two Isoforms of 68-kDa Type I Phosphatidylinositol4-phosphate 5-Kinase* , 1996, The Journal of Biological Chemistry.
[135] S. Rhee,et al. The Role of Carboxyl-terminal Basic Amino Acids in Gqα-dependent Activation, Particulate Association, and Nuclear Localization of Phospholipase C-β1* , 1996, The Journal of Biological Chemistry.
[136] K. Walsh,et al. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis , 1996, The Journal of cell biology.
[137] Gregory J. Parker,et al. The phosphatidylinositol 4-phosphate 5-kinase family. , 1996, Advances in enzyme regulation.
[138] M. Katan,et al. Mutations within a highly conserved sequence present in the X region of phosphoinositide-specific phospholipase C-delta 1. , 1995, The Biochemical journal.
[139] M. Vidal,et al. The retinoblastoma protein binds to a family of E2F transcription factors , 1993, Molecular and cellular biology.
[140] N. Divecha,et al. Nuclear diacylglycerol is increased during cell proliferation in vivo. , 1993, The Biochemical journal.
[141] A. Martelli,et al. Nuclear localization and signalling activity of phosphoinositidase Cβ in Swiss 3T3 cells , 1992, Nature.
[142] J. Boonstra,et al. A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. , 1992, The Journal of biological chemistry.
[143] Michael J. Berridge,et al. Inositol phosphates and cell signalling , 1989, Nature.
[144] A. Martelli,et al. Rapid changes in phospholipid metabolism in the nuclei of Swiss 3T3 cells induced by treatment of the cells with insulin-like growth factor I. , 1988, Biochemical and biophysical research communications.
[145] L. Cocco,et al. Synthesis of polyphosphoinositides in nuclei of Friend cells. Evidence for polyphosphoinositide metabolism inside the nucleus which changes with cell differentiation. , 1987, The Biochemical journal.
[146] C. Smith,et al. Characterization of a phosphatidylinositol 4-phosphate-specific phosphomonoesterase in rat liver nuclear envelopes. , 1984, Archives of biochemistry and biophysics.
[147] L. Cioé,et al. Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid. , 1981, Cancer research.